secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2026-07-01T20:15:26+00:00
Accession:  0001104659-26-079871
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 1.02, 2.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland closes $100M sale of branded products to Apotex; retains ifetroban pipeline
--------------------------------------------------------------------------------

- Sold Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, Vibativ for $100M cash.
- Over 99% of shareholder votes supported the transaction.
- Company retains ifetroban candidates for Duchenne, systemic sclerosis, IPF, cancer metastasis.
- Terminated $5.3M Pinnacle Bank credit facility; repaid in full.
- Pro forma shows ~$110M cash, no product revenue, net loss from continuing ops.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000110465926079871/0001104659-26-079871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000110465926079871/tm2619330d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-079871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer